Baltimore, MD; December 20, 2017 – KeraLink International is pleased to announce that J. Martin Heur, MD, PhD, has been appointed as the new Medical Director for their KeraLink West location in Los Angeles, California. As Medical Director, Dr. Heur will sit on the Quality Review Committee and will have a key role in advising KeraLink International regarding innovative research and training projects.
Dr. Heur brings years of expertise in his clinical specialty of the cornea and external disease from his research and medical practice. He is Associate Professor of Clinical Ophthalmology and Director of the Cornea and External Disease Fellowship Program at USC Roski Eye Institute. Dr. Heur is also a member of the Association for Research in Vision and Ophthalmology, the Cornea Society, and a fellow of the American Academy of Ophthalmology.
“I am excited to start as the Medical Director KeraLink West. I am looking forward to working with KeraLink to continue to provide excellent service to cornea surgeons and to explore new areas of research to improve eye banking,” said Dr. Heur.
Dr. Heur’s research interests focus on investigation of molecular mechanisms of corneal endothelial wound healing, and is supported by grants from the National Eye Institute and Research to Prevent Blindness.
Dr. Heur received MD and PhD degrees from the Physician Scientist Training Program at University of Cincinnati College of Medicine, where he was awarded an NIH Medical Scientist Training Program fellowship. He completed his residency training at Cole Eye Institute, Cleveland Clinic, followed by a fellowship in Cornea and External Disease and Refractive Surgery at the USC Department of Ophthalmology.
“Our entire team is excited to work with Dr. Heur,” said Art Kurz, KeraLink’s Vice President of Business Development. “His experience and expertise as a clinician and research scientist is right in line with our mission and our goal to advance the field of eye banking.”
About KeraLink International
KeraLink International is a non-profit, non-governmental network of eye banks and related programs committed to reversing corneal blindness wherever it exists. The organization accomplishes this by investing in world-class facilities, medical education, collaboration with other members of the transplant community, creative development campaigns and cutting-edge research, as well as by providing charitable tissue both domestically and internationally to patients in need. KeraLink International is proud that its cooperative relationships with multiple Organ Procurement Organizations and other eye banks allow it to extend its reach. With seven processing centers strategically located throughout the United States, KeraLink International is positioned to process and deliver high quality tissue to surgeons and their patients. In addition, KeraLink’s international arm, the International Federation of Eye Banks (IFEB), provides support, oversight and innovative programming assistance to 29 IFEB members around the world.